Last reviewed · How we verify
sulphadoxine-pyrimethamine intermittent preventive treatment
sulphadoxine-pyrimethamine intermittent preventive treatment is a Small molecule drug developed by London School of Hygiene and Tropical Medicine. It is currently in Phase 1 development.
At a glance
| Generic name | sulphadoxine-pyrimethamine intermittent preventive treatment |
|---|---|
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Improving Care Through Azithromycin Research for Infants in Africa (PHASE3)
- MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi (PHASE4)
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy (PHASE3)
- Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth (PHASE3)
- Parasite Clearance and Protection from Infection (PCPI) in Cameroon (PHASE3)
- Perennial Malaria Chemoprevention (PMC) in Cameroon
- Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sulphadoxine-pyrimethamine intermittent preventive treatment CI brief — competitive landscape report
- sulphadoxine-pyrimethamine intermittent preventive treatment updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI
Frequently asked questions about sulphadoxine-pyrimethamine intermittent preventive treatment
What is sulphadoxine-pyrimethamine intermittent preventive treatment?
sulphadoxine-pyrimethamine intermittent preventive treatment is a Small molecule drug developed by London School of Hygiene and Tropical Medicine.
Who makes sulphadoxine-pyrimethamine intermittent preventive treatment?
sulphadoxine-pyrimethamine intermittent preventive treatment is developed by London School of Hygiene and Tropical Medicine (see full London School of Hygiene and Tropical Medicine pipeline at /company/london-school-of-hygiene-and-tropical-medicine).
What development phase is sulphadoxine-pyrimethamine intermittent preventive treatment in?
sulphadoxine-pyrimethamine intermittent preventive treatment is in Phase 1.